Clinical Research Directory
Browse clinical research sites, groups, and studies.
FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
Sponsor: The George Institute
Summary
A multi-centre, prospective, blinded, randomised clinical trial of fludrocortisone compared with placebo in patients presenting with aneurysmal subarachnoid haemorrhage. The study aim is to determine if early administration of enteral fludrocortisone in aneurysmal subarachnoid haemorrhage reduce death and dependency at six months.
Official title: A Prospective, Blinded, Randomised Clinical Trial of Fludrocortisone Compared With Placebo in Critically Ill Patients Presenting With Aneurysmal Subarachnoid Haemorrhage
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
524
Start Date
2025-08-13
Completion Date
2030-07-31
Last Updated
2025-12-16
Healthy Volunteers
No
Conditions
Interventions
Fludrocortisone
small white tablet containing 100mcg of fludrocortsone
Placebo
Matched placebo tablet,
Locations (16)
John Hunter Hospital
New Lambton Heights, New South Wales, Australia
Nepean Hospital
Penrith, New South Wales, Australia
Prince of Wales Hospital
Randwick, New South Wales, Australia
Royal North Shore Hospital
St Leonards, New South Wales, Australia
Westmead Hospital
Westmead, New South Wales, Australia
Wollongong Hospital
Wollongong, New South Wales, Australia
Royal Brisbane Women's Hospital
Brisbane, Queensland, Australia
Gold Coast University Hospital
Gold Coast, Queensland, Australia
Townsville Hospital
Townsville, Queensland, Australia
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
Royal Hobart Hospital
Hobart, Tasmania, Australia
Monash Medical Centre
Clayton, Victoria, Australia
St Vincent's Hospital (Melbourne)
Fitzroy, Victoria, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
Auckland City Hospital
Auckland, New Zealand
Wellington Hospital
Wellington, New Zealand